PRF Technologies (PRFX) Cash from Operations (2020 - 2024)
PRF Technologies' (PRFX) quarterly Cash from Operations came in at 3530000.0 in Q2 2024, up 276.24% YoY from 938241.77 in Q3 2023, and up 195.53% on a QoQ basis from 3695000.0 in Q1 2024.
PRF Technologies (PRFX) Cash from Operations (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 5 years of Cash from Operations data on file, last reported at 3530000.0 in Q2 2024.
- Quarterly Cash from Operations rose 276.24% year-over-year to 3530000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was 2889000.0 (up 62.55% YoY) and the FY2025 annual result came in at 3955000.0, up 68.66% from the prior year.
- Cash from Operations grew to 3530000.0 in Q2 2024, from 3695000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 4785424000.0 in Q3 2021 to a low of 4788553000.0 in Q4 2021.
- A 5-year average of 1245166.67 and a median of 1571500.0 in 2022 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 2185225.11% in 2021, down 236605.54% in 2021.
- Tracing PRFX's Cash from Operations over 5 years: stood at 2023000.0 in 2020, then slumped by 236605.54% to 4788553000.0 in 2021, then soared by 99.94% to 2868000.0 in 2022, then surged by 45.89% to 1552000.0 in 2023, then jumped by 327.45% to 3530000.0 in 2024.
- The last three Cash from Operations figures came in at 3530000.0 (Q2 2024), 3695000.0 (Q1 2024), and 1552000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.45 Bn | 43.48 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.60 Bn | 39.95 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.45 Bn | 30.77 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.06 Bn | 19.40 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.99 Bn | 18.10 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.52 Bn | 15.13 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.98 Bn | 11.45 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | PRF Technologies | 640,715.70 | -3.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 3.53 Mn |
| Jun 30, 2024 | 3.53 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Dec 31, 2023 | -1.55 Mn |
| Dec 31, 2023 | -1.55 Mn |
| Sep 30, 2023 | -1.17 Mn |
| Sep 30, 2023 | -1.17 Mn |
| Jun 30, 2023 | -2.00 Mn |
| Jun 30, 2023 | -2.00 Mn |
| Mar 31, 2023 | -1.95 Mn |
| Mar 31, 2023 | -1.95 Mn |
| Dec 31, 2022 | -2.87 Mn |
| Dec 31, 2022 | -2.87 Mn |
| Sep 30, 2022 | -892,000.00 |
| Sep 30, 2022 | -892,000.00 |
| Jun 30, 2022 | -1.59 Mn |
| Jun 30, 2022 | -1.59 Mn |
| Mar 31, 2022 | -1.11 Mn |
| Mar 31, 2022 | -1.11 Mn |